[法国LILI (冠心内石化术) ]
Benjamin Honton1, Hakim Benamer2, Guillaume Cayla3
1Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France.
Annales de cardiologie et d'angeiologie
|November 4, 2024
概括
法国 - 利利登记处在未经选择的患有复杂冠状动脉病变的患者中调查血管内石 (IVL). 这项研究旨在提供IVL的现实数据.
科学领域:
- 干预心脏病学 干预心脏病学
- 心血管器械 心血管器械
- 医疗技术评估 医疗技术评估
背景情况:
- 静脉内石 (IVL) 已被批准用于冠状动脉化病变的准备,但临床试验往往排除复杂的病例.
- 来自CAD研究的现有数据有局限性,包括患者和病变选择,质疑IVL的现实应用性.
- 在未经选择的复杂冠状动脉病变患者群体中缺乏IVL使用的证据.
研究的目的:
- 评估静脉内立异 (IVL) 作为冠状动脉血管塑造中的辅助治疗的安全性和有效性.
- 在法国,评估IVL在全方位患者群体中的表现.
- 在复杂的冠状动脉病变中收集IVL的真实证据.
主要方法:
- 法国-利利是一个前性的,国家,学术注册.
- 登记册将注册500名患有复杂冠状动脉病变的受血管造形手术的患者.
- 主要终点是目标血管衰竭 (TVF) 一年,心脏死亡,MI (ARC-2) 和目标血管再血管化的复合,独立裁决.
主要成果:
- 目前正在对FRANCE-LILI注册表进行数据收集.
- 主要终点结果 (TVF在一年后) 正在等待.
- 该注册表旨在提供全面的安全性和有效性数据.
结论:
- 法国-利利注册表将提供有关常规临床实践中IVL使用的宝贵见解.
- 结果将解决目前关于IVL在未经选择的患有复杂冠状动脉病变的患者的证据缺口.
- 这项研究将有助于了解IVL在管理具有挑战性的冠状动脉疾病中的作用.
关键词:
结石化冠状动脉病变的病变.静脉内静脉直径三.里索特里普西 (Lithotripsie) 是一种冠状病毒内部的症状.冠状动脉损伤 (Lésions coronaires calcifiées) 已经化了斑块的准备 斑块的准备石碑的准备工作这是一个注册登记.登记处 登记处 登记处更多相关视频
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 19, 2020
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
相关概念视频
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...